Trial intelligence / Profile preview

Montelukast in Cat Allergen Challenge

NCT00092105Phase 3Completed

Sponsor
Organon & Co.
Start
Apr 2002
Primary completion
Jan 2003
Modality
Small Molecules
01

Overview

A Phase 3 trial of montelukast in asthma, allergic rhinitis (AR), sponsored by Organon & Co.. Started Apr 2002; status: completed.

02

Drugs

montelukast
03

Conditions

asthmaallergic rhinitis (AR)

Beyond the preview

Go deeper on NCT00092105.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00092105.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call